Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
11.21 USD | -0.18% | +5.46% | +11.43% |
Jun. 06 | Morgan Stanley Adjusts Price Target on Vir Biotechnology to $15 From $12, Maintains Equal-Weight Rating | MT |
Jun. 05 | Sector Update: Health Care Stocks Steady Premarket Wednesday | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+11.43% | 1.53B | |
+49.41% | 56.95B | |
+41.65% | 40.26B | |
-6.72% | 39.32B | |
-5.96% | 28.37B | |
+12.99% | 26.45B | |
-19.82% | 19.41B | |
+32.35% | 12.54B | |
-0.08% | 12.15B | |
+25.18% | 12.21B |
- Stock Market
- Equities
- VIR Stock
- News Vir Biotechnology, Inc.
- Insider Sell: Vir Biotechnology